Related Experiment Video
Updated: Apr 24, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
How ultra-processed foods modulate cardiometabolic risk: A 2 × 2 factorial randomized controlled trial protocol in
Marianne Rochette1, Amélie Charest2, Iris Gigleux2
1Centre Nutrition, santé et société (NUTRISS), Institut sur la nutrition et les aliments fonctionnels (INAF), Université Laval, Québec, QC G1V 0A6, Canada; École de nutrition, Faculté des sciences de l'agriculture et de l'alimentation, Université Laval, Québec, QC G1V 0A6, Canada.
Background:
Despite growing evidence linking overconsumption of ultra-processed foods (UPFs) to numerous adverse health outcomes, there is still no consensus regarding whether all UPFs are equally concerning for cardiovascular health, regardless of their nutrient profile.
Objective:
This 2 × 2 factorial randomized controlled trial aim to determine which feature(s) of UPFs, namely their poor nutrient profile or their underlying industrial processes, contribute to cardiometabolic risk.
Method:
120 adults, men and women, are randomly assigned to one of the four experimental 6-week diets: 1- Low-UPF diet (5% total energy) low in saturated fats (SFAs), added sugars and sodium; 2- Low-UPF diet (5% total energy) rich in SFAs, added sugars and sodium; 3- High UPF diet (75% total energy) low in SFAs, added sugars and sodium; 4- High UPF diet (75% total energy) rich in SFAs, added sugars and sodium. All foods and beverages are provided to participants under isoenergetic conditions. The high UPF diets are largely comprised of commercial foods with variable amounts of SFAs, added sugars and sodium. The low UPF diets are custom prepared with varying amounts of SFAs, added sugars and sodium to match the nutrient values of the high UPFs diets. Primary outcomes measured at baseline and post treatment are fasting LDL-C concentrations, insulin sensitivity (HOMA-IR) and daytime systolic ambulatory blood pressure (dtSBP).
Conclusion:
This randomized controlled trial will be the first to use fully controlled feeding conditions to disentangle out the individual effects of the industrial processing techniques from the poor nutrient content of UPFs on cardiometabolic risk.
Trial Registration:
ClinicalTrials.gov (ID NCT06538831), registered July 31, 2024.
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Atherosclerosis III: Management

